Clinically relevant factors that were significantly associated with cycle 1 FN were older age, increasing planned cyclophosphamide dose, increasing planned etoposide dose, a history of previous chemotherapy, a history of recent infection, and low baseline albumin <35 g/l. The gene discussed is ALB; the disease is infection.